(no IDC) an mrna multivalent approach including pre-erythrocytic-stage antigens and mosquito saliva antigens to broaden the immune targets against malaria infection

Ended Cooperative Agreement Awarded Last action

Award ID
HT94252320025
Recipient
Awarding agency
Obligated
$549,526

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Place of performance
Great Britain, United Kingdom

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment (no IDC) project title: an mrna multivalent approach including pre-erythrocytic-stage antigens and mosquito saliva antigens to broaden the immune targets… -$18,749
Original award $568,275

Quick answers

Who received award HT94252320025?

HT94252320025 was awarded to Conserv Bioscience LIMITED by Defense Health Agency (Department of Defense) on September 30, 2023.

How much is award HT94252320025 worth?

$549,526 has been obligated on HT94252320025.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award